Burga R - Search Results

1

Cord blood natural killer cells expressing a dominant negative TGF-β receptor: Implications for adoptive immunotherapy for glioblastoma.

Yvon ES, Burga R, Powell A, Cruz CR, Fernandes R, Barese C, Nguyen T, Abdel-Baki MS, Bollard CM. Yvon ES, et al. Among authors: burga r. Cytotherapy. 2017 Mar;19(3):408-418. doi: 10.1016/j.jcyt.2016.12.005. Epub 2017 Jan 19. Cytotherapy. 2017. PMID: 28109751

2

Improving efficacy of cancer immunotherapy by genetic modification of natural killer cells.

Burga RA, Nguyen T, Zulovich J, Madonna S, Ylisastigui L, Fernandes R, Yvon E. Burga RA, et al. Cytotherapy. 2016 Nov;18(11):1410-1421. doi: 10.1016/j.jcyt.2016.05.018. Epub 2016 Jul 12. Cytotherapy. 2016. PMID: 27421740 Review.

3

Designing Magnetically Responsive Biohybrids Composed of Cord Blood-Derived Natural Killer Cells and Iron Oxide Nanoparticles.

Burga RA, Khan DH, Agrawal N, Bollard CM, Fernandes R. Burga RA, et al. Bioconjug Chem. 2019 Mar 20;30(3):552-560. doi: 10.1021/acs.bioconjchem.9b00048. Epub 2019 Feb 22. Bioconjug Chem. 2019. PMID: 30779553

4

Engineering the TGFβ Receptor to Enhance the Therapeutic Potential of Natural Killer Cells as an Immunotherapy for Neuroblastoma.

Burga RA, Yvon E, Chorvinsky E, Fernandes R, Cruz CRY, Bollard CM. Burga RA, et al. Clin Cancer Res. 2019 Jul 15;25(14):4400-4412. doi: 10.1158/1078-0432.CCR-18-3183. Epub 2019 Apr 22. Clin Cancer Res. 2019. PMID: 31010834 Free PMC article.

5

Medulloblastoma rendered susceptible to NK-cell attack by TGFβ neutralization.

Powell AB, Yadavilli S, Saunders D, Van Pelt S, Chorvinsky E, Burga RA, Albihani S, Hanley PJ, Xu Z, Pei Y, Yvon ES, Hwang EI, Bollard CM, Nazarian J, Cruz CRY. Powell AB, et al. J Transl Med. 2019 Sep 23;17(1):321. doi: 10.1186/s12967-019-2055-4. J Transl Med. 2019. PMID: 31547819 Free PMC article.

6

Conjugating Prussian blue nanoparticles onto antigen-specific T cells as a combined nanoimmunotherapy.

Burga RA, Patel S, Bollard CM, Y Cruz CR, Fernandes R. Burga RA, et al. Nanomedicine (Lond). 2016 Jul;11(14):1759-67. doi: 10.2217/nnm-2016-0160. Epub 2016 Jul 7. Nanomedicine (Lond). 2016. PMID: 27389189 Free PMC article.

7

Prussian blue nanoparticle-based photothermal therapy combined with checkpoint inhibition for photothermal immunotherapy of neuroblastoma.

Cano-Mejia J, Burga RA, Sweeney EE, Fisher JP, Bollard CM, Sandler AD, Cruz CRY, Fernandes R. Cano-Mejia J, et al. Among authors: burga ra. Nanomedicine. 2017 Feb;13(2):771-781. doi: 10.1016/j.nano.2016.10.015. Epub 2016 Nov 5. Nanomedicine. 2017. PMID: 27826115 Free PMC article.

8

PLGA nanodepots co-encapsulating prostratin and anti-CD25 enhance primary natural killer cell antiviral and antitumor function.

Sweeney EE, Balakrishnan PB, Powell AB, Bowen A, Sarabia I, Burga RA, Jones RB, Bosque A, Cruz CRY, Fernandes R. Sweeney EE, et al. Among authors: burga ra. Nano Res. 2020 Mar;13(3):736-744. doi: 10.1007/s12274-020-2684-1. Epub 2020 Feb 21. Nano Res. 2020. PMID: 34079616 Free PMC article.

9

Beyond CAR T Cells: Other Cell-Based Immunotherapeutic Strategies Against Cancer.

Patel S, Burga RA, Powell AB, Chorvinsky EA, Hoq N, McCormack SE, Van Pelt SN, Hanley PJ, Cruz CRY. Patel S, et al. Front Oncol. 2019 Apr 10;9:196. doi: 10.3389/fonc.2019.00196. eCollection 2019. Front Oncol. 2019. PMID: 31024832 Free PMC article. Review.

10

Photothermal therapy improves the efficacy of a MEK inhibitor in neurofibromatosis type 1-associated malignant peripheral nerve sheath tumors.

Sweeney EE, Burga RA, Li C, Zhu Y, Fernandes R. Sweeney EE, et al. Among authors: burga ra. Sci Rep. 2016 Nov 11;6:37035. doi: 10.1038/srep37035. Sci Rep. 2016. PMID: 27833160 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

42 results

Search Page

Filters